Hims & Hers CCO exercises 900 options, sells 900 HIMS shares

Hims & Hers Health (HIMS) reported a Form 4 for Chief Commercial Officer Michael Chi.

Accepted by SEC EDGAR 10/14/2025 - 04:17 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Hims & Hers Health (HIMS) reported a Form 4 for Chief Commercial Officer Michael Chi. On 10/10/2025, he exercised 900 stock options at $6.82 and sold 900 Class A shares at $58.25, executed under a Rule 10b5-1 trading plan adopted on March 4, 2025. Following these transactions, he held 291,439 Class A shares directly and 115,362 derivative securities. The options vest over four years, with 1/48th vesting on September 10, 2022 and monthly thereafter.

Insider Trade Summary

Exercise and Sale: 900 shares ($46K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Chi Michael

Role Chief Commercial Officer

Sold 900 shs ($52K)

Approx. gross sale proceeds $52K

Approx. exercise cost $6K

Approx. pre-tax spread $46K

Share of Position Sold 0.31%

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	900	$0.00	$0.00
Exercise	Class A Common Stock	900	$6.82	$6K
Sale	Class A Common Stock	900	$58.25	$52K

Holdings After Transaction: Stock Option (right to buy) — 115,362 contracts (Direct); Class A Common Stock — 291,439 shares (Direct)

Holdings Before and After: Stock Option (right to buy), 116,262 to 115,362 contracts (Direct); Class A Common Stock, 291,439 to 291,439 shares (Direct)

Other Insiders: 5 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.
2. F2. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HIMS report on Form 4?

Michael Chi, the CCO, exercised 900 options at $6.82 and sold 900 Class A shares at $58.25 on 10/10/2025.

How many HIMS shares did the insider sell and at what price?

He sold 900 Class A shares at a price of $58.25.

What were the option exercise details for HIMS (HIMS)?

He exercised 900 stock options at an exercise price of $6.82.

What are the insider’s holdings after the reported HIMS transactions?

Post-trade, he held 291,439 Class A shares directly and 115,362 derivative securities.

Was the HIMS trade under a Rule 10b5-1 plan?

Yes. The trades were effected under a Rule 10b5-1 plan adopted on March 4, 2025.

What are the vesting terms of the HIMS options?

Options vest over 4 years: 1/48th on September 10, 2022, then 1/48th monthly thereafter.

What is the role of the reporting person at HIMS?

He is the Chief Commercial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Chi Michael

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/10/2025		M(1)		900	A	$6.82	292,339	D
Class A Common Stock	10/10/2025		S(1)		900	D	$58.25	291,439	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$6.82	10/10/2025		M(1)			900	(2)	08/10/2032	Class A Common Stock	900	$0	115,362	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

2. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Michael Chi	10/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.